Therese Bittermann, MD, MSCE
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Education:
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent linkBA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Description of Clinical Expertise
I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.Description of Research Expertise
I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policy-making and center variability in patient care. These efforts have spanned adult and pediatric transplant populations. I also have research interests in autoimmune hepatitis and alcohol-associated liver disease. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.Selected Publications
Pulaski M, Bittermann T, Taddei TH, Kaplan DE, Mahmud N: The Association Between Homelessness and Key Liver-Related Outcomes in Veterans With Cirrhosis American Journal of Gastroenterology Epub ahead of print, Oct 2023.Hirshorn RE, Schaubel DE, Abt PL, Reddy KR, Bittermann T: Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era Liver Transplantation Epub ahead of print, Sep 2023.
Rosenthal BE, Bittermann T: Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation? Liver Transplantation Epub ahead of print, Sep 2023.
Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T: Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience Liver Transplantation Epub ahead of print, Aug 2023.
Durkin C, Bittermann T: Liver transplantation for alcohol-associated hepatitis. Current Opinion in Organ Transplantation 28(2): 85-94, Apr 2023.
Ibeabuchi T, Li E, Bittermann T, Mahmud N, Abt PL: Can ex-situ normothermic perfusion improve graft survival compared to static cold storage among donation after circulatory death liver allografts? Liver Transplantation Epub ahead of print, Apr 2023.
Kathawate RG, Abt PL, Bittermann T: Center expansion of liver transplants using donation after circulatory death organs is associated with reduced overall waitlist mortality. Clinical Transplantation Epub ahead of print, Mar 2023.
Liapakis A, Agbim U, Bittermann T, Dew MA, Deng Y, Gan G, Emre S, Hunt HF, Olthoff KM, Locke JE, Jesse MT, Kumar V, Pillai A, Verna E, Lentine KL: A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation Epub ahead of print, Mar 2023.
Liapakis A, Jesse MT, Pillai A, Bittermann T, Dew MA, Emre S, Hunt H, Kumar V, Locke J, Mohammad S, Olthoff K, Verna EC, Lentine KL; LDLT Consensus Working Group: Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clinical Transplantation Epub ahead of print, Mar 2023.
Wood P, Huang YS, Sanchez L, Kitt E, Abt PL, Bittermann T: The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients. American Journal of Transplantation Epub ahead of print, Mar 2023.